Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

27.08.2026

Rasonque pancreatic cancer drug wins FDA approval

Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.

This article is for Health Matters subscribers

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

23.10.2026

ARV Tender Suffers a Blow as High Court Sets Aside Contracts

The High Court set aside R12.6bn in TLD contracts in the ARV tender, ordering Cipla’s inclusion and excluding Viatris and Innovata.

23.10.2026

Financial Stress Is the Leading Driver of Poor Mental Health

23.10.2026

Opioid Overprescribing Raises Safety Concerns

Experts warn that opioid overprescribing after minor surgery risks addiction and waste, and paracetamol and NSAIDs often suffice.